Objective To study the changes of the endothelial tissueplasminogenactivator reserve capacity in patients with acute coronary syndromes.
目的探讨急性冠状动脉综合征患者内皮组织纤溶酶原激活剂储备功能的变化规律。
2
This was accompanied by severe disruption of the blood-brain barrier and an increased rate of intracerebral hemorrhages after tissueplasminogenactivator treatment.
这一现象伴随血脑屏障的严重破坏和组织型纤维蛋白溶酶原激活剂治疗后的脑出血率增加。
3
Objective to observe the effect of recombinant tissueplasminogenactivator in the treatment of acute myocardial infarction.